A self-determination theory-based cognitive prosthetic to improve medication adherence in African American older adults with diabetes.
Exp GerontolJul 27, 2026 (epub)
William Bayer, Anthony A Sterns
✦ AI-curated · Sources linked
In 30 seconds
This randomized controlled trial evaluated the efficacy of MediTeddi, a cognitive prosthetic, in improving medication adherence among African American older adults with poorly controlled type 2 diabetes. The study found that participants using MediTeddi experienced a mean HbA1c reduction of 0.88 compared to 0.32 in the control group, indicating potential benefits in glycemic control and adherence.
Key findings
- In Study 1, the intervention group had a mean HbA1c reduction of 0.88 vs 0.32 in the control group.
- MMAS-4 adherence improved by a mean of 0.67 in the intervention group compared to no change in the control group.
- In Study 2, adherence increased significantly from 1.61 to 3.14 on the MMAS-4 scale.
- Participants in Study 2 also saw a 1.71-point reduction in HbA1c.
Why it matters
Improving medication adherence in older adults with diabetes is crucial for preventing complications. This study suggests that innovative tools like MediTeddi may enhance adherence and glycemic control, potentially leading to better health outcomes in this population.